Disclosures

William J. Gradishar, MD, FACP, FASCO

Betty Bramsen Professor of Breast Oncology and Chief, Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago

Received clinical research support/data safety monitoring board from Daiichi Sankyo, Genentech, Novartis, and Seattle Genetics

Served on scientific advisory board or as a consultant or expert witness for ambrx, AstraZeneca, Merck & Co, and Pfizer

Soo Park, MD

Associate Professor, Division of Hematology/Oncology, UC San Diego Moores Cancer Center,
San Diego, California

Received clinical research support/data safety monitoring board from Regeneron Pharmaceuticals

Served on scientific advisory board or as a consultant or expert witness for Regeneron Pharmaceuticals

Gregory J. Riely, MD, PhD

Vice Chair of Clinical Research, Department of Medicine, Memorial Sloan Kettering Cancer Center,
New York, New York

Received clinical research support/data safety monitoring board from Amgen, Chugai, Eli Lilly and Company, Genentech, Merck & Co., Mirati, Novartis Pharmaceuticals, Pfizer, Rain Therapeutics, and Takeda Pharmaceuticals North America

Served on scientific advisory board or as a consultant or expert witness for AstraZeneca Pharmaceuticals LP, Bayer HealthCare, Merck & Co., Mirati, Novartis Pharmaceuticals, Pfizer, and Takeda Pharmaceuticals North America

Medical Writers:

The following medical writers reported no conflicts of interest.

Jenna Carter, PhD; Vanessa A. Carter, BS; Celeste L. Dixon; Julia Cipriano, MS; Joseph Cupolo, MS; Bryna Goeking; Justine Landin, PhD; Victoria Kuhr, MS; Amy MacDonald, MS; Joshua Madera, MD; Margie Miller; Julian Anna Nowogrodzki; Susan Reckling, MA; Amanda E. Ruffino, BA; Chris Schimpf, MSW